Literature DB >> 30008291

Zika Virus Vaccine: Progress and Challenges.

Chao Shan1, Xuping Xie1, Pei-Yong Shi2.   

Abstract

The explosive emergence of Zika virus has inspired a global effort to develop vaccines. Zika virus, which is a flavivirus primarily transmitted by mosquitoes, can cause devastating congenital syndrome in fetuses of pregnant women, including microcephaly, craniofacial disproportion, spasticity, ocular abnormalities, and miscarriage. In adults, Zika infection has been linked to the autoimmune disorder Guillain-Barré syndrome. Thus, despite the current waning in newly reported Zika infections, an efficacious vaccine is urgently needed to help limit the emergence of another detrimental epidemic. Here we summarize the current status of the Zika vaccine pipeline and highlight the challenges for clinical efficacy trials.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30008291      PMCID: PMC6112613          DOI: 10.1016/j.chom.2018.05.021

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  35 in total

1.  Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Authors:  Angel Balmaseda; Karin Stettler; Raquel Medialdea-Carrera; Damaris Collado; Xia Jin; José Victor Zambrana; Stefano Jaconi; Elisabetta Cameroni; Saira Saborio; Francesca Rovida; Elena Percivalle; Samreen Ijaz; Steve Dicks; Ines Ushiro-Lumb; Luisa Barzon; Patricia Siqueira; David W G Brown; Fausto Baldanti; Richard Tedder; Maria Zambon; A M Bispo de Filippis; Eva Harris; Davide Corti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model.

Authors:  Beth D Kirkpatrick; Stephen S Whitehead; Kristen K Pierce; Cecilia M Tibery; Palmtama L Grier; Noreen A Hynes; Catherine J Larsson; Beulah P Sabundayo; Kawsar R Talaat; Anna Janiak; Marya P Carmolli; Catherine J Luke; Sean A Diehl; Anna P Durbin
Journal:  Sci Transl Med       Date:  2016-03-16       Impact factor: 17.956

3.  Modified mRNA Vaccines Protect against Zika Virus Infection.

Authors:  Justin M Richner; Sunny Himansu; Kimberly A Dowd; Scott L Butler; Vanessa Salazar; Julie M Fox; Justin G Julander; William W Tang; Sujan Shresta; Theodore C Pierson; Giuseppe Ciaramella; Michael S Diamond
Journal:  Cell       Date:  2017-02-17       Impact factor: 41.582

4.  Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells.

Authors:  Jinsheng Wen; William Weihao Tang; Nicholas Sheets; Julia Ellison; Alessandro Sette; Kenneth Kim; Sujan Shresta
Journal:  Nat Microbiol       Date:  2017-03-13       Impact factor: 17.745

5.  Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

Authors:  Pablo Tebas; Christine C Roberts; Kar Muthumani; Emma L Reuschel; Sagar B Kudchodkar; Faraz I Zaidi; Scott White; Amir S Khan; Trina Racine; Hyeree Choi; Jean Boyer; Young K Park; Sylvie Trottier; Celine Remigio; Diane Krieger; Susan E Spruill; Mark Bagarazzi; Gary P Kobinger; David B Weiner; Joel N Maslow
Journal:  N Engl J Med       Date:  2017-10-04       Impact factor: 91.245

6.  Zika Virus and the Guillain-Barré Syndrome - Case Series from Seven Countries.

Authors:  Thais Dos Santos; Angel Rodriguez; Maria Almiron; Antonio Sanhueza; Pilar Ramon; Wanderson K de Oliveira; Giovanini E Coelho; Roberto Badaró; Juan Cortez; Martha Ospina; Raquel Pimentel; Rolando Masis; Franklin Hernandez; Bredy Lara; Romeo Montoya; Beatrix Jubithana; Angel Melchor; Angel Alvarez; Sylvain Aldighieri; Christopher Dye; Marcos A Espinal
Journal:  N Engl J Med       Date:  2016-08-31       Impact factor: 91.245

7.  A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models.

Authors:  Chao Shan; Antonio E Muruato; Bruno T D Nunes; Huanle Luo; Xuping Xie; Daniele B A Medeiros; Maki Wakamiya; Robert B Tesh; Alan D Barrett; Tian Wang; Scott C Weaver; Pedro F C Vasconcelos; Shannan L Rossi; Pei-Yong Shi
Journal:  Nat Med       Date:  2017-04-10       Impact factor: 87.241

8.  Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.

Authors:  Albert To; Liana O Medina; Kenji O Mfuh; Michael M Lieberman; Teri Ann S Wong; Madhuri Namekar; Eileen Nakano; Chih-Yun Lai; Mukesh Kumar; Vivek R Nerurkar; Axel T Lehrer
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

9.  Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.

Authors:  Wanwisa Dejnirattisai; Piyada Supasa; Wiyada Wongwiwat; Alexander Rouvinski; Giovanna Barba-Spaeth; Thaneeya Duangchinda; Anavaj Sakuntabhai; Van-Mai Cao-Lormeau; Prida Malasit; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2016-06-23       Impact factor: 25.606

10.  A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage.

Authors:  Chao Shan; Antonio E Muruato; Brett W Jagger; Justin Richner; Bruno T D Nunes; Daniele B A Medeiros; Xuping Xie; Jannyce G C Nunes; Kaitlyn M Morabito; Wing-Pui Kong; Theodore C Pierson; Alan D Barrett; Scott C Weaver; Shannan L Rossi; Pedro F C Vasconcelos; Barney S Graham; Michael S Diamond; Pei-Yong Shi
Journal:  Nat Commun       Date:  2017-09-22       Impact factor: 17.694

View more
  31 in total

1.  Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.

Authors:  Anzhong Li; Miaoge Xue; Zayed Attia; Jingyou Yu; Mijia Lu; Chao Shan; Xueya Liang; Thomas Z Gao; Pei-Yong Shi; Mark E Peeples; Prosper N Boyaka; Shan-Lu Liu; Jianrong Li
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Small molecule grp94 inhibitors block dengue and Zika virus replication.

Authors:  Hussin A Rothan; Yongwang Zhong; Mark A Sanborn; Teow Chong Teoh; Jingjing Ruan; Rohana Yusof; Jun Hang; Mark J Henderson; Shengyun Fang
Journal:  Antiviral Res       Date:  2019-08-14       Impact factor: 5.970

3.  A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.

Authors:  Cindy Nürnberger; Bianca S Bodmer; Anna H Fiedler; Gülsah Gabriel; Michael D Mühlebach
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  mRNA Vaccines to Protect Against Diseases.

Authors:  Sunil Thomas; Ann Abraham
Journal:  Methods Mol Biol       Date:  2022

5.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

6.  Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge.

Authors:  Danielle Thompson; Ben Guenther; Darly Manayani; Jason Mendy; Jonathan Smith; Diego A Espinosa; Eva Harris; Jeff Alexander; Lo Vang; Christopher S Morello
Journal:  PLoS Negl Trop Dis       Date:  2022-07-06

7.  Inflammatory-dependent Sting activation induces antiviral autophagy to limit zika virus in the Drosophila brain.

Authors:  Elizabeth Delorme-Axford; Daniel J Klionsky
Journal:  Autophagy       Date:  2018-11-01       Impact factor: 16.016

8.  A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission.

Authors:  Xuping Xie; Dieudonné B Kum; Hongjie Xia; Huanle Luo; Chao Shan; Jing Zou; Antonio E Muruato; Daniele B A Medeiros; Bruno T D Nunes; Kai Dallmeier; Shannan L Rossi; Scott C Weaver; Johan Neyts; Tian Wang; Pedro F C Vasconcelos; Pei-Yong Shi
Journal:  Cell Host Microbe       Date:  2018-10-10       Impact factor: 21.023

Review 9.  Reverse genetic approaches for the development of Zika vaccines and therapeutics.

Authors:  Camila R Fontes-Garfias; Coleman K Baker; Pei-Yong Shi
Journal:  Curr Opin Virol       Date:  2020-06-18       Impact factor: 7.121

10.  Generation and preliminary characterization of vertebrate-specific replication-defective Zika virus.

Authors:  Shengfeng Wan; Shengbo Cao; Xugang Wang; Yanfei Zhou; Weidong Yan; Xinbin Gu; Tzyy-Choou Wu; Xiaowu Pang
Journal:  Virology       Date:  2020-10-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.